Trials / Completed
CompletedNCT04266691
Analysis of Driver Gene Mutation in Early Stage Non-small Cell Lung Cancer
Molecular Metastasis in Lymph Nodes is Associated With Survival of Patients With Stage I NSCLC
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 237 (actual)
- Sponsor
- Zhejiang Cancer Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Analysis of driver gene variation in early stage non-small cell lung cancer
Detailed description
Fluorescence quantitative polymerase chain reaction (PCR) was used to detect the variation of driver gene in regional lymph nodes of early stage non-small cell lung cancer (NSCLC), and to analyze the relationship between the variation and disease recurrence and survival prognosis. evaluate the effect of the variation of driving gene in lymph nodes of early stage NSCLC on prognosis, identify the high-risk factors that promote the recurrence and metastasis of early stage tumor. so as to improve the diagnosis and treatment path of lung cancer, provide important pathological basis for the clinical diagnosis and treatment of early stage non-small cell lung cancer, enable patients to receive more accurate treatment, and improve their survival prognosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | nonIntervention | nonIntervention |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2015-12-01
- Completion
- 2019-06-01
- First posted
- 2020-02-12
- Last updated
- 2020-02-12
Source: ClinicalTrials.gov record NCT04266691. Inclusion in this directory is not an endorsement.